Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ARO-APOC3
ARO-APOC3
FDA grants fast track designation to Arrowhead Pharmaceuticals’ ARO-APOC3 to reduce triglycerides
Pharmaceutical Business Review
Tue, 03/21/23 - 09:57 am
Arrowhead Pharmaceuticals
ARO-APOC3
triglycerides
familial chylomicronemia syndrome
fast track
FDA